LysRs-IN-1 is primarily used in research settings to study its inhibitory effects on lysyl-tRNA synthetase (LysRS), an enzyme involved in protein synthesis. By targeting LysRS, it helps researchers understand the enzyme's role in cellular processes, particularly in conditions where protein synthesis is dysregulated, such as in certain cancers or viral infections. This compound is also explored for its potential therapeutic applications, especially in diseases where inhibiting LysRS could disrupt the growth or survival of pathogenic cells. Its use in laboratory studies provides insights into developing novel treatments targeting protein synthesis pathways.